Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives"

doi:10.3390/jcm11123315

Editorial

. 2022 Jun 9;11(12):3315.

doi: 10.3390/jcm11123315.

Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives"

Kazuma Yamakawa¹

Affiliations

PMID: 35743386
PMCID: PMC9225217
DOI: 10.3390/jcm11123315

Editorial

Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives"

Kazuma Yamakawa. J Clin Med. 2022.

. 2022 Jun 9;11(12):3315.

doi: 10.3390/jcm11123315.

Author

Kazuma Yamakawa¹

Affiliation

¹ Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.

PMID: 35743386
PMCID: PMC9225217
DOI: 10.3390/jcm11123315

Abstract

Disseminated intravascular coagulation (DIC) is characterized by the systemic activation of blood coagulation that generates and deposits fibrin that causes microvascular thrombi to develop in various organs, which contributes to multiple organ dysfunction [...].

PubMed Disclaimer

Conflict of interest statement

K.Y. reported receiving research grants from Asahi Kasei Pharma and Nihon Pharmaceutical.

Cited by

Development and validation of a nomogram to predict mortality of patients with DIC in ICU.
Zeng Q, Lin Q, Zhong L, He L, Zhang N, Song J. Zeng Q, et al. Front Med (Lausanne). 2024 Jul 9;11:1425799. doi: 10.3389/fmed.2024.1425799. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39045415 Free PMC article.
A Narrative Review of Scoring Methods in Disseminated Intravascular Coagulation: Evaluating Diagnostic Accuracy and Clinical Utility.
Chaithanya P, Meshram RJ, Taksande A. Chaithanya P, et al. Cureus. 2024 Aug 17;16(8):e67052. doi: 10.7759/cureus.67052. eCollection 2024 Aug. Cureus. 2024. PMID: 39286675 Free PMC article. Review.

References

1. Gando S., Levi M., Toh C.H. Disseminated intravascular coagulation. Nat. Rev. Dis. Prim. 2016;2:16037. doi: 10.1038/nrdp.2016.37. - DOI - PubMed
1. Iba T., Levy J.H., Raj A., Warkentin T.E. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J. Clin. Med. 2019;8:728. doi: 10.3390/jcm8050728. - DOI - PMC - PubMed
1. Iba T., Levy J.H. Derangement of the endothelial glycocalyx in sepsis. J. Thromb. Haemost. 2019;17:283–294. doi: 10.1111/jth.14371. - DOI - PubMed
1. Umemura Y., Yamakawa K., Kiguchi T., Nishida T., Kawada M., Fujimi S. Hematological phenotype of COVID-19-induced coagulopathy: Far from typical sepsis-induced coagulopathy. J. Clin. Med. 2020;9:2875. doi: 10.3390/jcm9092875. - DOI - PMC - PubMed
1. REMAP-CAP Investigators. ACTIV-4a Investigators. ATTACC Investigators. Goligher E.C., Bradbury C.A., McVerry B.J., Lawler P.R., Berger J.S., Gong M.N., Carrier M., et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N. Engl. J. Med. 2021;385:777–789. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Gando S., Levi M., Toh C.H. Disseminated intravascular coagulation. Nat. Rev. Dis. Prim. 2016;2:16037. doi: 10.1038/nrdp.2016.37. - DOI - PubMed

[2] Gando S., Levi M., Toh C.H. Disseminated intravascular coagulation. Nat. Rev. Dis. Prim. 2016;2:16037. doi: 10.1038/nrdp.2016.37. - DOI - PubMed

[3] Iba T., Levy J.H., Raj A., Warkentin T.E. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J. Clin. Med. 2019;8:728. doi: 10.3390/jcm8050728. - DOI - PMC - PubMed

[4] Iba T., Levy J.H., Raj A., Warkentin T.E. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J. Clin. Med. 2019;8:728. doi: 10.3390/jcm8050728. - DOI - PMC - PubMed

[5] Iba T., Levy J.H. Derangement of the endothelial glycocalyx in sepsis. J. Thromb. Haemost. 2019;17:283–294. doi: 10.1111/jth.14371. - DOI - PubMed

[6] Iba T., Levy J.H. Derangement of the endothelial glycocalyx in sepsis. J. Thromb. Haemost. 2019;17:283–294. doi: 10.1111/jth.14371. - DOI - PubMed

[7] Umemura Y., Yamakawa K., Kiguchi T., Nishida T., Kawada M., Fujimi S. Hematological phenotype of COVID-19-induced coagulopathy: Far from typical sepsis-induced coagulopathy. J. Clin. Med. 2020;9:2875. doi: 10.3390/jcm9092875. - DOI - PMC - PubMed

[8] Umemura Y., Yamakawa K., Kiguchi T., Nishida T., Kawada M., Fujimi S. Hematological phenotype of COVID-19-induced coagulopathy: Far from typical sepsis-induced coagulopathy. J. Clin. Med. 2020;9:2875. doi: 10.3390/jcm9092875. - DOI - PMC - PubMed

[9] REMAP-CAP Investigators. ACTIV-4a Investigators. ATTACC Investigators. Goligher E.C., Bradbury C.A., McVerry B.J., Lawler P.R., Berger J.S., Gong M.N., Carrier M., et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N. Engl. J. Med. 2021;385:777–789. - PMC - PubMed

[10] REMAP-CAP Investigators. ACTIV-4a Investigators. ATTACC Investigators. Goligher E.C., Bradbury C.A., McVerry B.J., Lawler P.R., Berger J.S., Gong M.N., Carrier M., et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N. Engl. J. Med. 2021;385:777–789. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives"

Affiliation

Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives"

Author

Affiliation

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources